Oral Pyridorin (pyridoxamine) - NephroGenex
NephroGenex: Company Presentation (Nephrogenex) - Sep 19, 2014 - "Clinical Results"; "PYR-206"; "Mild to Moderate Diabetic Nephropathy – Dose 50 mg BID"; "Pyridorin at a 50 mg bid dose is well tolerated and slows the rate of SCr increase in mild to moderate disease patients" 
P2 data Diabetic Nephropathy • Renal Disease
http://nephrogenex.investorhq.businesswire.com/sites/nephrogenex.investorhq.businesswire.com/files/doc_library/file/NephroGenex_Corporate_Presentation.pdf
 
Sep 19, 2014
 
.
 
b4cc7c85-9849-4df6-bf29-8b48d03ec8e4.jpg